Hi All - I haven't been very active on this group, but I wanted to say hello and seek your input, if you're interested, in some of the advocacy work I'm doing on HIT, medical devices and innovation.
I was recently appointed to the ONC's Federal HIT Policy Committee Workgroup on FDASIA. The workgroup members were selected by ONC, FDA and FCC to provide guidance and input on a report to Congress required by FDASIA (the FDA reauthorization act of 2012), specifically advising on ways to create a regulatory framework that both protects patients AND promotes innovation.
I was appointed because of my roles as both a T1D and an HIT entrepreneur.
All of the meetings are public, so you can follow via Web cast and provide public comments at the end. However, as we prepare to develop the report for ONC, I would certainly be open to/welcome your input.
Here's the announcement from my company's Website, which includes links to other sources of information:
I look forward to hearing from you! - Anna